Skip to main content
SpringerLink
Log in

Heart Failure

  • Chapter
  • First Online:
Critical Care Study Guide

Abstract

After studying this chapter, you should be able to: Define congestive heart failure (CHF). Classify the epidemiology of CHF. Understand the morbidity and mortality statistics of CHF. Recognize the signs and symptoms of CHF. Know the major treatment algorithms of CHF. Understand the pharmacology and pathophysiology behind the treatment regimens. Understand the limitations of the treatment regimens.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rosamond W, Flegal K, Friday G, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69-e171.

    Article  PubMed  Google Scholar 

  2. Jain P, Massie BM, Gattis WA, Klein L, Gheorghiade M. Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization. Am Heart J. 2003;145:S3-S17.

    Article  PubMed  Google Scholar 

  3. The ADHERE Scientific Advisory Committee and Investigators; Adams KF Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the acute decompensated heart failure national registry (ADHERE). Am Heart J. 2005;149(2):209-216.

    Google Scholar 

  4. O’Connor CM, Gattis WA, Uretsky BF, et al. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flora International Randomized Survival Trial (FIRST). Am Heart J. 1999;138:78-86.

    Article  PubMed  Google Scholar 

  5. Cuffe MS, Califf RM, Adams KF Jr, et al. Outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. 2002;287:1541-1547.

    Article  PubMed  CAS  Google Scholar 

  6. Swedberg K, Idanpann-Heikkila U, et al. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316(23):1429-1435.

    Article  Google Scholar 

  7. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Eng J Med. 1991;325(5):293-302.

    Google Scholar 

  8. Packer M, Gheorghiade M, Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors: RADIANCE Study. N Eng J Med. 1993;329:1-7.

    Article  CAS  Google Scholar 

  9. Cooper HA, Dries DL, Davis CE, Shen YL, Domanksi MJ. Diuretics and risk arrhythmic death in patients with left ventricular dysfunction. Circulation. 1999;100:1311-1315.

    Article  PubMed  CAS  Google Scholar 

  10. Young JB, Gheorghiade M, Uretsky BF, et al. Superiority of “triple” drug therapy in heart failure: insights from the PROVED and RADIANCE trials – prospective randomized study of ventricular function and efficacy of digoxin, randomized assessment of digoxin and inhibitors of angiotensin-converting enzyme. J Am Coll Cardiol. 1998;32(3):686-692.

    Article  PubMed  CAS  Google Scholar 

  11. Granger CB, McMurray JJ, Yusuf S, et al. Effects of candesartan in patients with chronic heart failure and reduced left ventricular systolic function intolerant to angiotensin-converting enzyme inhibitors: the CHARM-alternative trial. Lancet. 2003;362:767-771.

    Article  PubMed  Google Scholar 

  12. The African-American Heart Failure Trial investigators; Taylor AL, Ziesche S, Yancy C, et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004;351:2049-2057.

    Google Scholar 

  13. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure: U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349-1355.

    Article  PubMed  CAS  Google Scholar 

  14. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet. 1999 June 12; 353 (9169): 2001-2007.

    Google Scholar 

  15. Tousoulis D, Charakida M, Stefanadi E, et al. Statins in heart failure. Beyond the lipid lowering effect. Int J Cardiol. 2007;115:144-150.

    Article  PubMed  Google Scholar 

  16. EPOCH Study Group. Effects of pimobendan on adverse cardiac events and physical activities in patients with mild to moderate chronic heart failure. Circ J. 2002;66:149-157.

    Article  Google Scholar 

  17. Gheoreghiade M, Teerlink JR, Mebazaa A. Pharmacology of new agents for acute heart failure syndromes. Am J Cardiol. 2005;96:68-73.

    Article  Google Scholar 

  18. Shin DD, Brandimarte F, De Luca L, et al. Review of current and investigational pharmacologic agents for acute heart failure syndromes. Am J Cardiol. 2007;99:4A-23A.

    Article  PubMed  CAS  Google Scholar 

  19. Konstam MA, Gheorghiade M. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST outcome trial. JAMA. 2007;297:1319-1331.

    Article  PubMed  CAS  Google Scholar 

  20. Costanzo MR. Ultrafiltration versus IV diuretics for patients hospitalized for acute decompensated congestive heart failure: a prospective randomized clinical trial: UNLOAD. Presented at the American College of Cardiology Annual Scientific Session. Atlanta, GA; 2006: 11-14, March.

    Google Scholar 

  21. Konstam MA, Czerska B, Bohm M, et al. Continuous aortic flow augmentation: hemodynamic and renal responses to a novel percutaneous intervention in patients with decompensated heart failure. Circulation. 2005;112:3107-3114.

    Article  PubMed  Google Scholar 

  22. Desvigne-Nickens OH, Miller LW, Gupta Rose EA, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435-1443.

    Article  PubMed  Google Scholar 

  23. Mather P, Konstam M. The use of percutaneous mechanical devices in the treatment of heart failure. Curr Heart Failure Rep. 2007;4:43-47.

    Article  Google Scholar 

  24. The Criteria Committee, New York Heart Association, Inc. Diseases of the Heart and Blood Vessels. Nomenclature and Criteria for Diagnosis. 6th ed. Boston: Little, Brown, 1964:114.

    Google Scholar 

Additional Reading

  • Practice Guideline: Focused Update 2009 Focused update: ACCF/AHA Guidelines for the diagnosis and management of heart failure in adults. A report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation. 2009;119:1977-2016.

    Google Scholar 

  • ACC/AHA Task Force Report. Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol. 1995;26:1376-1398.

    Article  Google Scholar 

  • Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study (CONSENSUS). N Engl J Med. 1986;314:1547-1552.

    Article  PubMed  CAS  Google Scholar 

  • Dracup K, Walden JA, Stevenson LW, Brecht ML. Quality of life in patients with advanced heart failure. J Heart Lung Transplant. 1992;11:273-279.

    PubMed  CAS  Google Scholar 

  • Gillum RF. Epidemiology of heart failure in the United States. Am Heart J. 1993;126:1042-1047.

    Article  PubMed  CAS  Google Scholar 

  • Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol. 1992;20:248-254.

    Article  PubMed  CAS  Google Scholar 

  • The SAVE Investigators; Pfeffer MA, Braunwald E, Moyè LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med. 1992;327:669-677.

    Google Scholar 

  • Stevenson WG, Stevenson LW, Middlekauff HR, et al. Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol. 1995;26:1417-1423.

    Article  PubMed  CAS  Google Scholar 

  • Tresch DD, McGough MF. Heart failure with normal systolic function. A common disorder in older people. J Am Geriatr Soc. 1995;43:1035-1042.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Advanced Heart Failure and Cardiac Transplant Center, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, 19002, USA

    Paul J. Mather MD

  2. Pulmonary and Critical Care Medicine, Temple University School of Medicine, Philadelphia, PA, 19140, USA

    Gilbert E. D’Alonzo DO

Authors
  1. Paul J. Mather MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gilbert E. D’Alonzo DO
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. School of Medicine, Temple University, N. Broad St. 3420, Philadelphia, 19140, USA

    Gerard J. Criner

  2. Dept. Medicine, Temple University, N. Broad Street 3401, Philadelphia, 19140, USA

    Rodger E. Barnette

  3. School of Medicine, Temple University, N. Broad St. 3420, Philadelphia, 19140, USA

    Gilbert E. D'Alonzo

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Mather, P.J., D’Alonzo, G.E. (2010). Heart Failure. In: Criner, G., Barnette, R., D'Alonzo, G. (eds) Critical Care Study Guide. Springer, New York, NY. https://doi.org/10.1007/978-0-387-77452-7_18

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-77452-7_18

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-77327-8

  • Online ISBN: 978-0-387-77452-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation